Termination Clause Example from Business Contracts
This example Termination clause appears in 13 contracts from 8 companies
Underwriting Agreement related to the Common Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on February 21, 2019)
Underwriting Agreement related to the Common Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on October 8, 2019)
Underwriting Agreement, dated June 18, 2019, by and among Kura Oncology, Inc. and SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 19, 2019)
Underwriting Agreement, dated May 5, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on May 6, 2020)
Underwriting Agreement, dated December 8, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC, Credit Suisse Securities (USA) LLC, Barclays Capital Inc., and Stifel, Nicolaus... (Filed With SEC on December 9, 2020)
Form of Underwriting Agreement (Filed With SEC on June 10, 2019)
Form of Underwriting Agreement (Filed With SEC on May 22, 2020)
Underwriting Agreement, dated August 3, 2021, by and among Avidity Biosciences, Inc. and Cowen and Company, LLC, SVB Leerink LLC, Evercore Group L.L.C., and Wells Fargo... (Filed With SEC on August 4, 2021)
Underwriting Agreement, dated December 15, 2022, by and among Avidity Biosciences, Inc. and Cowen and Company, LLC, Evercore Group L.L.C., and Wells Fargo Securities, LLC, as... (Filed With SEC on December 16, 2022)
Form of Underwriting Agreement (Filed With SEC on February 1, 2021)
Form of Underwriting Agreement (Filed With SEC on March 21, 2022)
2,500,000 Shares ADAMAS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 7, 2016)
[] Voyager Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 28, 2015)